About Debut
Debut is a Healthcare company based in San Diego (United States) founded in 2019 by Gregory Weiss and Joshua Britton. Enzymes for biotherapeutic creation and modification are provided and manufactured. Debut has raised $125.81 million across 8 funding rounds from investors including DIC Global, Material Impact and BOLD. Its chief executive, as recorded, is Joshua Britton. Debut offers products and services including Cosmetic Active Ingredients. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is Debut Biotechnology, Inc.
Company details
Debut was founded in 2019 in San Diego, United States, within the biotech sector. Enzymes are manufactured and supplied for biotherapeutic development and modification. Immobilization enzymes are offered for therapeutic uses, alongside continuous biomanufacturing cartridges, immobilized cells, and enzymes to support ongoing production processes.
- Headquarters San Diego, United States
- Founders Gregory Weiss, Joshua Britton
- SectorsHealthcare
- Email••••••••
- Website debutbiotech.com
- Social LinkedIn X
- Legal Name Debut Biotechnology, Inc.
- Total Equity Funding$125.81M (USD)
in 8 rounds
- Latest Funding Round$20M (USD), Series B
Aug 2025
- InvestorsDIC Global
& 17 more
Products & Services of Debut
Debut offers a comprehensive portfolio of products and services, including Cosmetic Active Ingredients.
Science-based ingredients for sustainable beauty solutions.
Funding Insights of Debut
Debut has successfully raised a total of $125.81M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $125.81M
- Total Rounds 8
- Last Round Series B — $20M
- First Round $2.61M
(Jan 2020)
- Investors Count 18
All 8 funding rounds of Debut with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $20M | Series B | – | – | |
| Oct 2023 | $40M | Series B | – | BOLD | – |
| Jun 2023 | Series B | – | INX International Ink | – | |
| Jun 2023 | $34M | Series B | – | BOLD | |
| Nov 2021 | $4M | Series A | – | – | – |
| Aug 2021 | $23M | Series A | – | Material Impact | |
| Sep 2020 | $2.2M | Seed | – | – | – |
| Jan 2020 | $2.61M | Seed | – | KdT Ventures |
18 investors in total: 18 institutional.
Investors in Debut
Debut has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include DIC Global, Material Impact and BOLD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| lorealboldventures.com | ||||
Venture capital is provided for disruptive scientific innovations. | finestructure.vc | Cambridge, United States | ||
Venture capital firm backed by GS Group and focused on climate tech, and energy sectors | gsfutures.vc | San Mateo, United States | ||
Venture capital is provided by Cavallo Ventures in multiple sectors. | cavallovc.com | San Francisco, United States | ||
| cultiviansbx.com | ||||
Tech focused VC fund | acvc.partners | Palo Alto, United States | ||
Early-stage companies in science and technology are supported by Humboldt Fund. | 2020 | humboldtfund.com | ||
Seed stage tech-focused VC firm investing primarily in the US | cantos.vc | San Francisco, United States | ||
Early-stage investments are made in frontier science ventures. | kdtvc.com | Black Mountain, United States | ||
Micro-venture capital firm investing in pre-seed to seed stage startups | better.vc | Oakland, United States |
Investor details for Debut
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Debut
21 people are tracked at Debut (10 in leadership, 11 in team).
| Name | Role | Group |
|---|---|---|
Gregory Weiss | Co-Founder | Leadership |
Joshua Britton | Co-Founder & CEO | Leadership |
Venus Soriano-Felgenhauer, PHR CBP CPSP | Head of Human Resources | Leadership |
Kadie Burton | Vice President Operations | Leadership |
Mark Wall | Chief Scientific Officer | Leadership |
Laura Ziv | Head of Marketing & Communications | Leadership |
Ariba Alvi | Senior Art Director | Leadership |
Helen Wahle | Director of Ecommerce & Digital Marketing | Leadership |
Rich La | CMO & Supply Chain Manager | Leadership |
Venus Soriano | Head of Human Resource | Leadership |
Jim Branch | Corporate Controller | Team |
Maria Palomares | Principal Scientist, Formulation | Team |
Meghan Sircar | Influencer Community Management Lead | Team |
Hongjun Huang | Senior Scientist | Team |
Morgan Connolly | Scientist | Team |
Nicholas Brideau | SVP, R&D | Team |
Jeff Wang | Senior Scientist | Team |
Zachary Friedman | Digital Marketing Analytics Manager | Team |
Anthony Agbay | Associate Scientist | Team |
Monica Manzano | Human Resources Generalist | Team |
1 more people are available in the full profile.
Complete people profiles for Debut
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Debut
3 dated milestones of Debut across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Debut is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Series B, of $20.0M.
Web traffic of Debut
The website of Debut (debutbiotech.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▼ 19.4% vs previous month
Websites whose visitors overlap most with Debut. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| singulargenomics.com | 100% | 3.2K | #5,664,473 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Debut (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Debut
Complete news archive for Debut
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Debut
Debut was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Debut is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Joshua Britton is the CEO of Debut, as recorded in our data. They have also founded this company.
Debut is a funded company, having raised a total of $125.81M across 8 funding rounds to date. The company's 1st funding round was a Seed of $2.61M, raised on Jan 2020.
Debut was founded in 2019 in San Diego, United States, within the biotech sector. Enzymes are manufactured and supplied for biotherapeutic development and modification. Immobilization enzymes are offered for therapeutic uses, alongside continuous biomanufacturing cartridges, immobilized cells, and enzymes to support ongoing production processes.
Debut offers Cosmetic Active Ingredients.
Debut has 18 investors. Key investors include DIC Global, Material Impact, BOLD, INX International Ink, and Fine Structure Ventures.
Debut operates through Debut Biotechnology, Inc..